NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

>>Glioblastoma treatment has improved in the past 26 years. Half of people with glioblastoma now live two years or more following diagnosis.

“When Tom was diagnosed, 5 percent of patients lived for two years or longer after diagnosis,” Chicoine said. “Research done locally and globally, like identifying genetic markers for increased glioblastoma risk, are important strides in survivorship.”

https://www.muhealth.org/our-stories/26-years-and-counting-leading-edge-glioblastoma-treatment-gives-tom-more-time